BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pokhriyal R, Hariprasad R, Kumar L, Hariprasad G. Chemotherapy Resistance in Advanced Ovarian Cancer Patients. Biomark Cancer 2019;11:1179299X19860815. [PMID: 31308780 DOI: 10.1177/1179299X19860815] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 20.0] [Reference Citation Analysis]
Number Citing Articles
1 Mao G, Xin D, Wang Q, Lai D. NO generation damages mitochondria in ovarian cancer cells sodium molybdate inhibits the growth of ovarian cancer cells via inducing both ferroptosis and apoptosis. Free Radic Biol Med 2022:S0891-5849(22)00077-6. [PMID: 35219846 DOI: 10.1016/j.freeradbiomed.2022.02.023] [Reference Citation Analysis]
2 Wang Z, Li F, Wei M, Zhang S, Wang T. Circadian Clock Protein PERIOD2 Suppresses the PI3K/Akt Pathway and Promotes Cisplatin Sensitivity in Ovarian Cancer. Cancer Manag Res 2020;12:11897-908. [PMID: 33244267 DOI: 10.2147/CMAR.S278903] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Borghese C, Casagrande N, Corona G, Aldinucci D. Adipose-Derived Stem Cells Primed with Paclitaxel Inhibit Ovarian Cancer Spheroid Growth and Overcome Paclitaxel Resistance. Pharmaceutics 2020;12:E401. [PMID: 32349462 DOI: 10.3390/pharmaceutics12050401] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Jiang L, Hou R. Tetrandrine Reverses Paclitaxel Resistance in Human Ovarian Cancer via Inducing Apoptosis, Cell Cycle Arrest Through β-Catenin Pathway. Onco Targets Ther 2020;13:3631-9. [PMID: 32431514 DOI: 10.2147/OTT.S235533] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Silva F, Coelho F, Peixoto A, Pinto P, Martins C, Frombach AS, Santo VE, Brito C, Guimarães A, Félix A. Establishment and characterization of a novel ovarian high-grade serous carcinoma cell line-IPO43. Cancer Cell Int 2022;22:175. [PMID: 35501869 DOI: 10.1186/s12935-022-02600-3] [Reference Citation Analysis]
6 Yang L, Zhang W, Qiu Q, Su Z, Tang M, Bai P, Si W, Zhu Z, Liu Y, Yang J, Kuang S, Liu J, Yan W, Shi M, Ye H, Yang Z, Chen L. Discovery of a Series of Hydroxamic Acid-Based Microtubule Destabilizing Agents with Potent Antitumor Activity. J Med Chem 2021;64:15379-401. [PMID: 34648295 DOI: 10.1021/acs.jmedchem.1c01451] [Reference Citation Analysis]
7 Bi J, Zhang Y, Malmrose PK, Losh HA, Newtson AM, Devor EJ, Thiel KW, Leslie KK. Blocking autophagy overcomes resistance to dual histone deacetylase and proteasome inhibition in gynecologic cancer. Cell Death Dis 2022;13:59. [PMID: 35039480 DOI: 10.1038/s41419-022-04508-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Zaleskis G, Garberytė S, Pavliukevičienė B, Valinčius G, Characiejus D, Mauricas M, Kraśko JA, Žilionytė K, Žvirblė M, Pašukonienė V. Doxorubicin uptake in ascitic lymphoma model: resistance or curability is governed by tumor cell density and prolonged drug retention. J Cancer 2020;11:6497-506. [PMID: 33046971 DOI: 10.7150/jca.46066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Pathania S, Khan MI, Kumar A, Gupta AK, Rani K, Ramesh Parashar T, Jayaram J, Ranjan Mishra P, Srivastava A, Mathur S, Hari S, Hariprasad G. Proteomics of Sentinel Lymph Nodes in Early Breast Cancer for Identification of Thymidylate Synthase as a Potential Biomarker to Flag Metastasis: A Preliminary Study. Cancer Manag Res 2020;12:4841-54. [PMID: 32606973 DOI: 10.2147/CMAR.S255684] [Reference Citation Analysis]
10 Zhang LY, Yu JY, Leng YL, Zhu RR, Liu HX, Wang XY, Yang TT, Guo YN, Tang JL, Zhang XC. MiR-181c sensitizes ovarian cancer cells to paclitaxel by targeting GRP78 through the PI3K/Akt pathway. Cancer Gene Ther 2021. [PMID: 34145425 DOI: 10.1038/s41417-021-00356-y] [Reference Citation Analysis]
11 Lucà R, Assenza MR, Maiullari F, Pieroni L, Maiullari S, Federici G, Marini F, Rizzi R, Urbani A, Soddu S, Moretti F. Inhibition of the mTOR pathway and reprogramming of protein synthesis by MDM4 reduce ovarian cancer metastatic properties. Cell Death Dis 2021;12:558. [PMID: 34052831 DOI: 10.1038/s41419-021-03828-z] [Reference Citation Analysis]
12 Zhang S, Cheng J, Quan C, Wen H, Feng Z, Hu Q, Zhu J, Huang Y, Wu X. circCELSR1 (hsa_circ_0063809) Contributes to Paclitaxel Resistance of Ovarian Cancer Cells by Regulating FOXR2 Expression via miR-1252. Mol Ther Nucleic Acids 2020;19:718-30. [PMID: 31945729 DOI: 10.1016/j.omtn.2019.12.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
13 Oyama Y, Shigeta S, Tokunaga H, Tsuji K, Ishibashi M, Shibuya Y, Shimada M, Yasuda J, Yaegashi N. CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents. PLoS One 2021;16:e0251079. [PMID: 34161330 DOI: 10.1371/journal.pone.0251079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Salgado-albarrán M, Späth J, González-barrios R, Baumbach J, Soto-reyes E. CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy. npj Syst Biol Appl 2022;8. [DOI: 10.1038/s41540-022-00214-z] [Reference Citation Analysis]
15 Ghoneum A, Almousa S, Warren B, Abdulfattah AY, Shu J, Abouelfadl H, Gonzalez D, Livingston C, Said N. Exploring the clinical value of tumor microenvironment in platinum-resistant ovarian cancer. Semin Cancer Biol 2021:S1044-579X(21)00003-1. [PMID: 33476723 DOI: 10.1016/j.semcancer.2020.12.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Casagrande N, Borghese C, Agostini F, Durante C, Mazzucato M, Colombatti A, Aldinucci D. In Ovarian Cancer Multicellular Spheroids, Platelet Releasate Promotes Growth, Expansion of ALDH+ and CD133+ Cancer Stem Cells, and Protection against the Cytotoxic Effects of Cisplatin, Carboplatin and Paclitaxel. Int J Mol Sci 2021;22:3019. [PMID: 33809553 DOI: 10.3390/ijms22063019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Flat W, Borowski S, Paraschiakos T, Blechner C, Windhorst S. DIAPH1 facilitates paclitaxel-mediated cytotoxicity of ovarian cancer cells. Biochem Pharmacol 2021;197:114898. [PMID: 34968485 DOI: 10.1016/j.bcp.2021.114898] [Reference Citation Analysis]
18 Leiping C, Xiao W, Xiaoping L, Liu J, Pan F, Ferraro P. Automatic removal of phase aberration in holographic microscopy for drug sensitivity detection of ovarian cancer cells. OSA Continuum 2020;3:1856. [DOI: 10.1364/osac.391773] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 McFadden M, Singh SK, Oprea-Ilies G, Singh R. Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers. Cancers (Basel) 2021;13:5480. [PMID: 34771642 DOI: 10.3390/cancers13215480] [Reference Citation Analysis]
20 Santos-Lopez A, Marshall CW, Haas AL, Turner C, Rasero J, Cooper VS. The roles of history, chance, and natural selection in the evolution of antibiotic resistance. Elife 2021;10:e70676. [PMID: 34431477 DOI: 10.7554/eLife.70676] [Reference Citation Analysis]
21 Banstola A, Jeong JH, Yook S. Immunoadjuvants for cancer immunotherapy: A review of recent developments. Acta Biomater 2020;114:16-30. [PMID: 32777293 DOI: 10.1016/j.actbio.2020.07.063] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 14.5] [Reference Citation Analysis]
22 Li M, Zhang S, Ma Y, Yang Y, An R. Role of hsa‑miR‑105 during the pathogenesis of paclitaxel resistance and its clinical implication in ovarian cancer. Oncol Rep 2021;45:84. [PMID: 33846814 DOI: 10.3892/or.2021.8035] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Piktel E, Ościłowska I, Suprewicz Ł, Depciuch J, Marcińczyk N, Chabielska E, Wolak P, Wollny T, Janion M, Parlinska-Wojtan M, Bucki R. ROS-Mediated Apoptosis and Autophagy in Ovarian Cancer Cells Treated with Peanut-Shaped Gold Nanoparticles. Int J Nanomedicine 2021;16:1993-2011. [PMID: 33727811 DOI: 10.2147/IJN.S277014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
24 Ly TTG, Yun J, Ha JS, Kim YJ, Jang WB, Van Le TH, Rethineswaran VK, Choi J, Kim JH, Min SH, Lee DH, Yang JS, Chung JS, Kwon SM. Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation against Ovarian Cancer Metastasis. Int J Mol Sci 2022;23:944. [PMID: 35055132 DOI: 10.3390/ijms23020944] [Reference Citation Analysis]
25 Bi J, Newtson AM, Zhang Y, Devor EJ, Samuelson MI, Thiel KW, Leslie KK. Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing. Cancers (Basel) 2021;13:2901. [PMID: 34200645 DOI: 10.3390/cancers13122901] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Rzhevskiy A, Kapitannikova A, Malinina P, Volovetsky A, Aboulkheyr Es H, Kulasinghe A, Thiery JP, Maslennikova A, Zvyagin AV, Ebrahimi Warkiani M. Emerging role of circulating tumor cells in immunotherapy. Theranostics 2021;11:8057-75. [PMID: 34335980 DOI: 10.7150/thno.59677] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
27 Hwang WY, Lee M, Suh DH, Kim K, No JH, Kim YB, Kim JH. Risk factors for and prognosis of carboplatin-related hypersensitivity in patients with epithelial ovarian cancer. Arch Gynecol Obstet 2022. [PMID: 35044514 DOI: 10.1007/s00404-022-06403-9] [Reference Citation Analysis]
28 Barez SR, Atar AM, Aghaei M. Mechanism of inositol-requiring enzyme 1-alpha inhibition in endoplasmic reticulum stress and apoptosis in ovarian cancer cells. J Cell Commun Signal 2020;14:403-15. [PMID: 32200504 DOI: 10.1007/s12079-020-00562-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Lee H, Kim JW, Lee DS, Min SH. Combined Poziotinib with Manidipine Treatment Suppresses Ovarian Cancer Stem-Cell Proliferation and Stemness. Int J Mol Sci 2020;21:E7379. [PMID: 33036254 DOI: 10.3390/ijms21197379] [Reference Citation Analysis]
30 Fabi F, Adam P, Parent S, Tardif L, Cadrin M, Asselin E. Pharmacologic inhibition of Akt in combination with chemotherapeutic agents effectively induces apoptosis in ovarian and endometrial cancer cell lines. Mol Oncol 2021;15:2106-19. [PMID: 33338300 DOI: 10.1002/1878-0261.12888] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Zhu Y, Ferri-Borgogno S, Sheng J, Yeung TL, Burks JK, Cappello P, Jazaeri AA, Kim JH, Han GH, Birrer MJ, Mok SC, Wong STC. SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment. Cancers (Basel) 2021;13:1777. [PMID: 33917869 DOI: 10.3390/cancers13081777] [Reference Citation Analysis]
32 Zhang K, Ying H, Zhao R, Chen Y, Deng Q. Capilliposide from Lysimachia capillipes promotes terminal differentiations and reverses paclitaxel resistance in A2780T cells of human ovarian cancer by regulating Fos/Jun pathway. Chinese Herbal Medicines 2021. [DOI: 10.1016/j.chmed.2021.09.009] [Reference Citation Analysis]
33 Barboza JR, Pereira FAN, Fernandes RA, Vasconcelos CC, Cartágenes MDSS, Oliveira Lopes AJ, Melo AC, Guimarães IDS, Rocha CQD, Ribeiro MNS. Cytotoxicity and Pro-Apoptotic, Antioxidant and Anti-Inflammatory Activities of Geopropolis Produced by the Stingless Bee Melipona fasciculata Smith. Biology (Basel) 2020;9:E292. [PMID: 32942772 DOI: 10.3390/biology9090292] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Khella CA, Mehta GA, Mehta RN, Gatza ML. Recent Advances in Integrative Multi-Omics Research in Breast and Ovarian Cancer. J Pers Med 2021;11:149. [PMID: 33669749 DOI: 10.3390/jpm11020149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
35 Phelps DL, Borley JV, Brown R, Takáts Z, Ghaem-Maghami S; Royal College of Obstetricians and Gynaecologists. The use of biomarkers to stratify surgical care in women with ovarian cancer: Scientific Impact Paper No. 69 March 2022: Scientific Impact Paper No. 69 May 2022. BJOG 2022. [PMID: 35437905 DOI: 10.1111/1471-0528.17142] [Reference Citation Analysis]
36 Shahriary S, Tafvizi F, Khodarahmi P, Shaabanzadeh M. Phyto-mediated synthesis of CuO nanoparticles using aqueous leaf extract of Artemisia deserti and their anticancer effects on A2780-CP cisplatin-resistant ovarian cancer cells. Biomass Conv Bioref . [DOI: 10.1007/s13399-022-02436-x] [Reference Citation Analysis]
37 Cerqueira M, Belmonte-reche E, Gallo J, Baltazar F, Bañobre-lópez M. Magnetic Solid Nanoparticles and Their Counterparts: Recent Advances towards Cancer Theranostics. Pharmaceutics 2022;14:506. [DOI: 10.3390/pharmaceutics14030506] [Reference Citation Analysis]
38 Ryu J, Thomas SN. Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer. Molecules 2021;26:2674. [PMID: 34063568 DOI: 10.3390/molecules26092674] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Su KM, Gao HW, Chang CM, Lu KH, Yu MH, Lin YH, Liu LC, Chang CC, Li YF, Chang CC. Synergistic AHR Binding Pathway with EMT Effects on Serous Ovarian Tumors Recognized by Multidisciplinary Integrated Analysis. Biomedicines 2021;9:866. [PMID: 34440070 DOI: 10.3390/biomedicines9080866] [Reference Citation Analysis]
40 Pathania S, Khan MI, Bandyopadhyay S, Singh SS, Rani K, Parashar TR, Jayaram J, Mishra PR, Srivastava A, Mathur S, Hari S, Vanamail P, Hariprasad G. iTRAQ proteomics of sentinel lymph nodes for identification of extracellular matrix proteins to flag metastasis in early breast cancer. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-12352-9] [Reference Citation Analysis]
41 Mengie Ayele T, Tilahun Muche Z, Behaile Teklemariam A, Bogale A, Chekol Abebe E. Role of JAK2/STAT3 Signaling Pathway in the Tumorigenesis, Chemotherapy Resistance, and Treatment of Solid Tumors: A Systemic Review. JIR 2022;Volume 15:1349-64. [DOI: 10.2147/jir.s353489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Kumar P, Mukundan MK, Sehrawat A, Sundriyal D. Tripe palms and Malignant Acanthosis Nigricans: More than a diagnostic pointer. Cancer Rep (Hoboken) 2021;4:e1307. [PMID: 33074559 DOI: 10.1002/cnr2.1307] [Reference Citation Analysis]
43 Dlamini Z, Francies FZ, Hull R, Marima R. Artificial intelligence (AI) and big data in cancer and precision oncology. Comput Struct Biotechnol J 2020;18:2300-11. [PMID: 32994889 DOI: 10.1016/j.csbj.2020.08.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
44 Wyciszkiewicz A, Lach MS, Wróblewska JP, Michalak M, Suchorska WM, Kalinowska A, Michalak S. The involvement of small heat shock protein in chemoresistance in ovarian cancer - in vitro study. EXCLI J 2021;20:935-47. [PMID: 34177409 DOI: 10.17179/excli2021-3706] [Reference Citation Analysis]
45 Zhang L, Zhao W, Huang J, Li F, Sheng J, Song H, Chen Y. Development of a Dendritic Cell/Tumor Cell Fusion Cell Membrane Nano-Vaccine for the Treatment of Ovarian Cancer. Front Immunol 2022;13:828263. [PMID: 35251013 DOI: 10.3389/fimmu.2022.828263] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Tsuyoshi H, Orisaka M, Fujita Y, Asare-Werehene M, Tsang BK, Yoshida Y. Prognostic impact of Dynamin related protein 1 (Drp1) in epithelial ovarian cancer. BMC Cancer 2020;20:467. [PMID: 32448194 DOI: 10.1186/s12885-020-06965-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
47 Choi J, Lee N, Wang Y, Hong J, Son SR, Gu D, Jang DS, Choi J. 1′-Acetoxyeugenol Acetate Isolated from Thai Ginger Induces Apoptosis in Human Ovarian Cancer Cells by ROS Production via NADPH Oxidase. Antioxidants 2022;11:293. [DOI: 10.3390/antiox11020293] [Reference Citation Analysis]
48 Moon S, Ok Y, Hwang S, Lim YS, Kim HY, Na YJ, Yoon S. A Marine Collagen-Based Biomimetic Hydrogel Recapitulates Cancer Stem Cell Niche and Enhances Progression and Chemoresistance in Human Ovarian Cancer. Mar Drugs 2020;18:E498. [PMID: 33003514 DOI: 10.3390/md18100498] [Reference Citation Analysis]
49 Martin-Gonzalez P, Crispin-Ortuzar M, Rundo L, Delgado-Ortet M, Reinius M, Beer L, Woitek R, Ursprung S, Addley H, Brenton JD, Markowetz F, Sala E. Integrative radiogenomics for virtual biopsy and treatment monitoring in ovarian cancer. Insights Imaging 2020;11:94. [PMID: 32804260 DOI: 10.1186/s13244-020-00895-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
50 Duan M, Ulibarri J, Liu KJ, Mao P. Role of Nucleotide Excision Repair in Cisplatin Resistance. Int J Mol Sci 2020;21:E9248. [PMID: 33291532 DOI: 10.3390/ijms21239248] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
51 Indini A, Nigro O, Lengyel CG, Ghidini M, Petrillo A, Lopez S, Raspagliesi F, Trapani D, Khakoo S, Bogani G. Immune-Checkpoint Inhibitors in Platinum-Resistant Ovarian Cancer. Cancers (Basel) 2021;13:1663. [PMID: 33916221 DOI: 10.3390/cancers13071663] [Reference Citation Analysis]
52 Akter S, Rahman MA, Hasan MN, Akhter H, Noor P, Islam R, Shin Y, Rahman MH, Gazi MS, Huda MN, Nam NM, Chung J, Han S, Kim B, Kang I, Ha J, Choe W, Choi TG, Kim SS. Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements. Cells 2022;11:650. [DOI: 10.3390/cells11040650] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
53 Guo R, Xu Q, Liu L, Liu H, Liu Y, Wei W, Qin Y. Bioactive Hexapeptide Reduced the Resistance of Ovarian Cancer Cells to DDP by Affecting HSF1/HSP70 Signaling Pathway. J Cancer 2021;12:6081-93. [PMID: 34539881 DOI: 10.7150/jca.62285] [Reference Citation Analysis]
54 Siraj AK, Pratheeshkumar P, Divya SP, Parvathareddy SK, Alobaisi KA, Thangavel S, Siraj S, Al-Badawi IA, Al-Dayel F, Al-Kuraya KS. Krupple-Like Factor 5 is a Potential Therapeutic Target and Prognostic Marker in Epithelial Ovarian Cancer. Front Pharmacol 2020;11:598880. [PMID: 33424607 DOI: 10.3389/fphar.2020.598880] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Khetan R, Dharmayanti C, Gillam TA, Kübler E, Klingler-Hoffmann M, Ricciardelli C, Oehler MK, Blencowe A, Garg S, Albrecht H. Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines. Cancers (Basel) 2022;14:2362. [PMID: 35625966 DOI: 10.3390/cancers14102362] [Reference Citation Analysis]
56 Aldinucci D, Borghese C, Casagrande N. The CCL5/CCR5 Axis in Cancer Progression. Cancers (Basel) 2020;12:E1765. [PMID: 32630699 DOI: 10.3390/cancers12071765] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 17.0] [Reference Citation Analysis]
57 Xu T, Wang M, Jiang L, Ma L, Wan L, Chen Q, Wei C, Wang Z. CircRNAs in anticancer drug resistance: recent advances and future potential. Mol Cancer 2020;19:127. [PMID: 32799866 DOI: 10.1186/s12943-020-01240-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
58 Binder PS, Hashim YM, Cripe J, Buchanan T, Zamorano A, Vangveravong S, Mutch DG, Hawkins WG, Powell MA, Spitzer D. The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09367-w] [Reference Citation Analysis]
59 Bahar E, Kim JY, Kim HS, Yoon H. Establishment of Acquired Cisplatin Resistance in Ovarian Cancer Cell Lines Characterized by Enriched Metastatic Properties with Increased Twist Expression. Int J Mol Sci 2020;21:E7613. [PMID: 33076245 DOI: 10.3390/ijms21207613] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
60 Mertens RT, Parkin S, Awuah SG. Cancer cell-selective modulation of mitochondrial respiration and metabolism by potent organogold(iii) dithiocarbamates. Chem Sci 2020;11:10465-82. [PMID: 34094305 DOI: 10.1039/d0sc03628e] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
61 Dongol S, Zhang Q, Qiu C, Sun C, Zhang Z, Wu H, Kong B. IQGAP3 promotes cancer proliferation and metastasis in high-grade serous ovarian cancer. Oncol Lett 2020;20:1179-92. [PMID: 32724358 DOI: 10.3892/ol.2020.11664] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Ranjan A, Ramachandran S, Gupta N, Kaushik I, Wright S, Srivastava S, Das H, Srivastava S, Prasad S, Srivastava SK. Role of Phytochemicals in Cancer Prevention. Int J Mol Sci 2019;20:E4981. [PMID: 31600949 DOI: 10.3390/ijms20204981] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 15.3] [Reference Citation Analysis]
63 González M, Ovejero-Sánchez M, Vicente-Blázquez A, Álvarez R, Herrero AB, Medarde M, González-Sarmiento R, Peláez R. Microtubule Destabilizing Sulfonamides as an Alternative to Taxane-Based Chemotherapy. Int J Mol Sci 2021;22:1907. [PMID: 33673002 DOI: 10.3390/ijms22041907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
64 Ovejero-Sánchez M, González-Sarmiento R, Herrero AB. Synergistic effect of Chloroquine and Panobinostat in ovarian cancer through induction of DNA damage and inhibition of DNA repair. Neoplasia 2021;23:515-28. [PMID: 33930758 DOI: 10.1016/j.neo.2021.04.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Pisano S, Lenna S, Healey GD, Izardi F, Meeks L, Jimenez YS, Velazquez OS, Gonzalez D, Conlan RS, Corradetti B. Assessment of the immune landscapes of advanced ovarian cancer in an optimized in vivo model. Clin Transl Med 2021;11:e551. [PMID: 34709744 DOI: 10.1002/ctm2.551] [Reference Citation Analysis]
66 Li N, Yang L, Zuo H. Arborinine suppresses ovarian cancer development through inhibition of LSD1. Life Sci 2021;291:120275. [PMID: 34979197 DOI: 10.1016/j.lfs.2021.120275] [Reference Citation Analysis]
67 Sharbatoghli M, Vafaei S, Aboulkheyr Es H, Asadi-Lari M, Totonchi M, Madjd Z. Prediction of the treatment response in ovarian cancer: a ctDNA approach. J Ovarian Res 2020;13:124. [PMID: 33076944 DOI: 10.1186/s13048-020-00729-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
68 Piktel E, Oscilowska I, Suprewicz Ł, Depciuch J, Marcińczyk N, Chabielska E, Wolak P, Głuszek K, Klimek J, Zieliński PM, Marzec MT, Savage PB, Parlińska-Wojtan M, Bucki R. Peanut-Shaped Gold Nanoparticles with Shells of Ceragenin CSA-131 Display the Ability to Inhibit Ovarian Cancer Growth In Vitro and in a Tumor Xenograft Model. Cancers (Basel) 2021;13:5424. [PMID: 34771587 DOI: 10.3390/cancers13215424] [Reference Citation Analysis]
69 Homayoun M, Ghasemnezhad Targhi R, Soleimani M. Anti-proliferative and anti-apoptotic effects of grape seed extract on chemo-resistant OVCAR-3 ovarian cancer cells. Res Pharm Sci 2020;15:390-400. [PMID: 33312217 DOI: 10.4103/1735-5362.293517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
70 Ruan S, Zhang H, Tian X, Zhang Z, Huang H, Shi C, Liu W, Jiang X, Huang D, Tao F. PHD Finger Protein 19 Enhances the Resistance of Ovarian Cancer Cells to Compound Fuling Granule by Protecting Cell Growth, Invasion, Migration, and Stemness. Front Pharmacol 2020;11:150. [PMID: 32180719 DOI: 10.3389/fphar.2020.00150] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 Miree O, Srivastava SK, Dasgupta S, Singh S, Rocconi R, Singh AP. Current and Futuristic Roadmap of Ovarian Cancer Management: An Overview. Adv Exp Med Biol 2021;1330:1-19. [PMID: 34339027 DOI: 10.1007/978-3-030-73359-9_1] [Reference Citation Analysis]
72 A Youness R, Kamel R, A Elkasabgy N, Shao P, A Farag M. Recent Advances in Tannic Acid (Gallotannin) Anticancer Activities and Drug Delivery Systems for Efficacy Improvement; A Comprehensive Review. Molecules 2021;26:1486. [PMID: 33803294 DOI: 10.3390/molecules26051486] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
73 Martincuks A, Li PC, Zhao Q, Zhang C, Li YJ, Yu H, Rodriguez-Rodriguez L. CD44 in Ovarian Cancer Progression and Therapy Resistance-A Critical Role for STAT3. Front Oncol 2020;10:589601. [PMID: 33335857 DOI: 10.3389/fonc.2020.589601] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
74 Cardillo N, Russo D, Newtson A, Reyes H, Lyons Y, Devor E, Bender D, Goodheart MJ, Gonzalez-Bosquet J. Identification of Novel lncRNAs in Ovarian Cancer and Their Impact on Overall Survival. Int J Mol Sci 2021;22:1079. [PMID: 33499129 DOI: 10.3390/ijms22031079] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Alvero AB, Hanlon D, Pitruzzello M, Filler R, Robinson E, Sobolev O, Tedja R, Ventura A, Bosenberg M, Han P, Edelson RL, Mor G. Transimmunization restores immune surveillance and prevents recurrence in a syngeneic mouse model of ovarian cancer. Oncoimmunology 2020;9:1758869. [PMID: 32566387 DOI: 10.1080/2162402X.2020.1758869] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]